Cell Biology and Histology

Projects

Projects per year 1991 1997 1999 2011 2013 2020

• 5 Active
• 98 Finished

Projects per year

Search results

• Active

  ADSI143: Interne overdrachten van UZ voor wetenschappelijk onderzoek

  van Grunsven, L. & Geerts, A.

  2/07/07 → …

  Project: Fundamental

• ADSP19: Sponsoring Workshops, Meetings and PhD United activities

  van Grunsven, L. & Geerts, A.

  2/02/05 → …

  Project: Fundamental

• 3943320708: Master and Ph. D. Studenten met Abos beurs Opleiding

  Geerts, A.

  1/10/94 → …

  Project: Fundamental

• GIFT78609: Donnation for the unit CYTO

  Bouwens, L.

  1/10/91 → …

  Project: Fundamental

• 3913220080: BRANDSCHADE F. BOLLENGIER

  Wisse, E.

  1/10/91 → …

  Project: Fundamental

• Finished

  OZRSRF20: Development of novel gene and cell therapy approaches for the treatment of degenerative muscle disorders - SRF mandate

  Chuah, M.

  1/10/15 → 30/09/20

  Project: Fundamental

• OZRSRF17: Molecular and cellular characterization of liver fibrosis and regeneration - SRF mandate

  van Grunsven, L.

  1/10/14 → 31/12/18

  Project: Fundamental

• SRP41: SRP (Groeiers): Next-generation gene therapy by computational vector design and immune stealth nanotechnology

  VandenDriessche, T. & Chuah, M.

  1/03/14 → 28/02/19

  Project: Fundamental

• FWOAL705: Development of non-viral gene therapy for hemophilia with innovative hyperactive transposon technology

  VandenDriessche, T.

  1/01/14 → 31/12/17

  Project: Fundamental

• FWOAL707: In vivo genome engineering based on the CRISPR / Cas system: a new platform for functional genome analysis and gene therapy

  Chuah, M.

  1/01/14 → 31/12/17

  Project: Fundamental

• FWOAL706: miRNA modulation in cancer with the help of designer Transcription Activator-Like Effector Nucleases (TALENs): a new platform for oncological research

  VandenDriessche, T.

  1/01/14 → 31/12/17

  Project: Fundamental

• FWOTM671: Development of novel "immune stealth" nanotechnology for gene therapy of hemophilia: pre-clinical validation and underlying mechanisms

  Chuah, M.

  1/10/13 → 30/06/14

  Project: Fundamental

• AII99: Research Grant: AFM Lettre d'engagement. Gene therapy for hereditary muscle diseases using novel AAV immune stealth nanotechnology

  VandenDriessche, T. & Chuah, M.

  1/10/13 → 31/03/15

  Project: Fundamental

• AII100: Research Grant: AFM Lettre d'engagement. Hepatic gene therapy for hemophilia using integration-defective lentiviral vectors: effects of miRNA regulation on induction of immune tolerance.

  VandenDriessche, T. & Chuah, M.

  1/10/13 → 31/03/15

  Project: Fundamental

• OZR2484: Bilateral cooperation in the framework of mutal doctoral projects - Bench fee Joint PhD VUB-KUL, Mario Di Matteo

  VandenDriessche, T.

  1/04/13 → 31/03/14

  Project: Fundamental

• OZR2483: Bilateral cooperation in the framework of mutual doctoral projects - Bench Fee Joint Phd VUB-KUL, Mariana Loperfido

  Chuah, M.

  1/04/13 → 31/03/14

  Project: Fundamental

• OZR2485: Bilateral cooperation in the framework of mutual doctoral projects - Bench fee Joint PhD VUB-KUL, Melvin Yesid Rincon Acelas

  VandenDriessche, T.

  1/04/13 → 31/03/14

  Project: Fundamental

• FWOAL689: The link between hypoxia and progenitor cells during liver carcinogenesis

  van Grunsven, L. & Van Vlierberghe, H.

  1/01/13 → 31/12/16

  Project: Fundamental

• FWOAL687: Extensive characterization of different human liver progenitor cell populations

  van Grunsven, L. & Roskams, T.

  1/01/13 → 31/12/16

  Project: Fundamental

• IWT622: Liver progenitor cells, their secretome and liver repair

  van Grunsven, L.

  1/01/13 → 31/12/16

  Project: Fundamental

• IWT619: Modulation of liver fibrosis by liposome-mediated selective targeting of hepatic stellate cells

  van Grunsven, L.

  1/01/13 → 4/06/17

  Project: Fundamental

• FWOAL690: Cardiovascular and muscle-specific "targeting" for gene therapy of neuromuscular disorders

  VandenDriessche, T. & Chuah, M.

  1/01/13 → 31/12/16

  Project: Fundamental

• AII86: Research Grant: AFM Letter of Agreement(M. Chuah) De novo design and validation of tissue-specific regulatory elements for heart and muscle-directed gene therapy.

  Chuah, M. & VandenDriessche, T.

  20/09/12 → 20/09/14

  Project: Fundamental

• AII98: Letter of Agreement Designer transcription activator -like effector nucleases (dTALENSs) for gene correction in myotonic dystrophy

  Chuah, M. & VandenDriessche, T.

  14/06/12 → 13/06/14

  Project: Fundamental

• FWOAL616: Myotonic dystrophy type 1 (DM1)-specific induced pluripotent stem cells (iPS): an innovative platform for myogenic and cardiomyogenic differentiation and validation of novel therapeutic approaches

  Chuah, M. & VandenDriessche, T.

  1/01/12 → 31/12/15

  Project: Fundamental

• ADSI315: Interne overdracht van Willy Gepts Fonds.

  VandenDriessche, T. & Chuah, M.

  1/01/12 → 31/12/12

  Project: Fundamental

• FWOAL651: Immune stealth nanotechnology for gene therapy of hemophilia 'A': mechanisms and translational implications

  VandenDriessche, T. & Chuah, M.

  1/01/12 → 31/12/15

  Project: Fundamental

• OZR2270: EU-bonuskrediet type B2c voor EU FP7 project met startdatum vanaf 1/1/2011: PERSIST (FP7-HEALTH-2007-1,4-4)

  VandenDriessche, T. & Chuah, M.

  1/10/11 → 31/12/12

  Project: Fundamental

• OZR2273: Translational Liver Cell Biology Alliance

  van Grunsven, L. & Colle, I.

  1/09/11 → 1/09/15

  Project: Fundamental

• OZR2230: New finance model research: ZAP startcredit 2010

  Chuah, M.

  1/07/11 → 31/12/12

  Project: Fundamental

• AII72: Special Project Award: Immune stealth AAV nanoparticles for gene therapy of hemophilia A.

  VandenDriessche, T. & Chuah, M.

  1/07/11 → 30/06/13

  Project: Fundamental

• OZR2228: Startcredit OZR

  VandenDriessche, T.

  22/06/11 → 22/06/16

  Project: Fundamental

• BRGEOZ135-B: PROLONGATION: BruStem (2): Regenerative medicine of the liver using synergistic mixtures of immature or mature human hepatocytes with mesenchymal stem/progenitor cells or with hepatic stellate cells

  van Grunsven, L. & Rogiers, V.

  1/06/11 → 31/05/14

  Project: Fundamental

• GOA78: Interplay between Epigenetic Modification Mechanisms and microRNAs - EPIGEN

  Rogiers, V., Vanderkerken, K., van Grunsven, L. & VandenDriessche, T.

  1/01/11 → 31/12/15

  Project: Fundamental

• FWOAL608: Development of stem cell gene therapy for Duchenne muscular dystrophy

  VandenDriessche, T., Chuah, M. & Sampaolesi, M.

  1/01/11 → 31/12/14

  Project: Fundamental

• EU376-A: HeMiBio (related to project EU376-B)

  van Grunsven, L.

  1/01/11 → 31/12/15

  Project: Fundamental

• FWOAL609: Hepatische gentherapie voor hemofilie met integratiedefectieve lentivirale vectoren: effect van miRNA regulatie op de inductie van immune tolerantie.

  Chuah, M. & VandenDriessche, T.

  1/01/11 → 31/12/14

  Project: Fundamental

• OZR2108: The hepatic progenitor cell niche under experimental conditions and in human liver disease

  van Grunsven, L.

  1/01/11 → 31/12/11

  Project: Fundamental

• EU374: PERSIST: Persisting Transgenesis.

  VandenDriessche, T. & Chuah, M.

  1/01/11 → 30/06/13

  Project: Fundamental

• IWT515: The Role of Autophagy in Liver Fibrosis.

  Thoen, L., van Grunsven, L. & van Grunsven, L.

  1/01/11 → 31/12/14

  Project: Fundamental

• OZR2151: IWT Overbruggingsbeurs (6 maanden): Titel wordt later aangevuld

  van Grunsven, L.

  1/01/11 → 30/06/11

  Project: Fundamental

• AII65: Research Grant: EHA Fellowship (Dr. Janka Matrai) Hepatic gene therapy for hemophilia using integration-defective lentiviral vectors: Effect of miRNA regulation on induction of immune tolerance.

  VandenDriessche, T., Chuah, M. & Matrai, J.

  1/01/11 → 31/12/12

  Project: Fundamental

• EU380: CLINIGENE: European Network for the Advancement of Clinical Gene transfer and Therapy.

  VandenDriessche, T. & Chuah, M.

  1/01/11 → 31/10/11

  Project: Fundamental

• ANI70: Role of microRNA in hepatocarcinogenesis: in vivo validation, mechanisms and therapeutic implications.

  VandenDriessche, T. & Chuah, M.

  1/12/10 → 31/12/12

  Project: Fundamental

• OZR2136: IWT Opvangbeurs (3 maanden): Titel wordt later aangevuld

  van Grunsven, L.

  1/10/10 → 31/12/10

  Project: Fundamental

• IWT471: Functional Human HEPatocytes, Stellate Cells and Sinusoidal Endothelial Cells from STEM Cells (HEPSTEM)

  van Grunsven, L., Verfaillie, C., Cornelissen, M., Roskams, T., Dubruel, P., Vanfleteren, J. & Himmelreich, U.

  1/11/09 → 31/10/13

  Project: Fundamental

• OZR2002: Distinct roles for non muscle myosin II isoforms in mouse hepatic stellate cells

  Reynaert, H., van Grunsven, L. & Liu, Z.

  1/10/09 → 31/03/10

  Project: Fundamental

• OZR1797: Analysis of HDAC repressor complexes with a function during liverfibrosis.

  van Grunsven, L.

  1/01/09 → 31/12/09

  Project: Fundamental

• FWOAL498: Analysis of HDAC repressor complexes with a function during liver fibrosis

  van Grunsven, L., Geerts, A., Lahoutte, T. & Huylebroeck, D.

  1/01/09 → 31/12/12

  Project: Fundamental

• FWOAL494: Role of angiogenesis and angiogenetic factors (VEGF, PLGF) in portal hypertension and fibrosis formation in animal models of cirrhosis, steatosis and portal hypertension

  Geerts, A., Reynaert, H., van Grunsven, L. & Colle, I.

  1/01/09 → 31/12/12

  Project: Fundamental